The effect of hospital-acquired infection with Clostridium difficile on length of stay in hospital is not yet fully understood. Alan J. Forster, of the Clinical Epidemiology Program at Ottawa Hospital Research Institute, and colleagues, determined the independent impact of hospital-acquired infection with C. difficile on length of stay in hospital.
The researchers conducted a retrospective observational cohort study of admissions to hospital between July 1, 2002, and Mar. 31, 2009, at a single academic hospital. They measured the association between infection with hospital-acquired C. difficile and time to discharge from hospital using Kaplan-Meier methods and a Cox multivariable proportional hazards regression model. They controlled for baseline risk of death and accounted for C. difficile as a time-varying effect.
Hospital-acquired infection with C. difficile was identified in 1,393 of 136 877 admissions to hospital (overall risk 1.02%, 95% confidence interval [CI] 0.97%1.06%). The crude median length of stay in hospital was greater for patients with hospital-acquired C. difficile (34 d) than for those without C. difficile (8 d). Survival analysis showed that hospital-acquired infection with C. difficile increased the median length of stay in hospital by six days. In adjusted analyses, hospital-acquired C. difficile was significantly associated with time to discharge, modified by baseline risk of death and time to acquisition of C. difficile. The hazard ratio for discharge by day 7 among patients with hospital-acquired C. difficile was 0.55 (95% CI 0.390.70) for patients in the lowest decile of baseline risk of death and 0.45 (95% CI 0.320.58) for those in the highest decile; for discharge by day 28, the corresponding hazard ratios were 0.74 (95% CI 0.600.87) and 0.61 (95% CI 0.530.68).
The researchers concluded that hospital-acquired infection with C. difficile significantly prolonged length of stay in hospital independent of baseline risk of death. Their research was published in the Canadian Medical Association Journal.
Reference: Forster AJ, Taljaard M, Oake N, Wilson K, Roth V and van Walrave C. The effect of hospital-acquired infection with Clostridium difficile on length of stay in hospital. CMAJ Dec. 5, 2011. doi: 10.1503/cmaj.110543
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
CDC Urges Vigilance: New Recommendations for Monitoring and Testing H5N1 Exposures
July 11th 2025With avian influenza A(H5N1) infections surfacing in both animals and humans, the CDC has issued updated guidance calling for aggressive monitoring and targeted testing to contain the virus and protect public health.
Getting Down and Dirty With PPE: Presentations at HSPA by Jill Holdsworth and Katie Belski
June 26th 2025In the heart of the hospital, decontamination technicians tackle one of health care’s dirtiest—and most vital—jobs. At HSPA 2025, 6 packed workshops led by experts Jill Holdsworth and Katie Belski spotlighted the crucial, often-overlooked art of PPE removal. The message was clear: proper doffing saves lives, starting with your own.
Spring Into Safety: How Seasonal Deep Cleaning Strengthens Hospital Infection Control
June 13th 2025Rooted in ancient rituals of renewal, spring-cleaning has evolved from cultural tradition to a vital infection prevention strategy in modern hospitals—one that blends seasonal deep cleaning with advanced disinfection to reduce pathogens, improve air quality, and protect patients.